InnoCare Pharma's Orelabrutinib Gains NMPA Approval for First-line CLL/SLL Treatment
CompanyDrug

InnoCare Pharma’s Orelabrutinib Gains NMPA Approval for First-line CLL/SLL Treatment

Chipscreen Biosciences Cuts Private Placement Proceeds to RMB 950 Million
CompanyDeals

Chipscreen Biosciences Cuts Private Placement Proceeds to RMB 950 Million

Shanghai Junshi Biosciences' Loqtorzi Receives NMPA Approval for Melanoma Treatment
CompanyDrug

Shanghai Junshi Biosciences’ Loqtorzi Receives NMPA Approval for Melanoma Treatment

Innovent Biologics' Aoyixin Wins NMPA Approval for First-line NSCLC Treatment
CompanyDrug

Innovent Biologics’ Aoyixin Wins NMPA Approval for First-line NSCLC Treatment

CSPC Pharmaceutical Group Gains NMPA Approval for SYH2068 siRNA Clinical Trials
CompanyDrug

CSPC Pharmaceutical Group Gains NMPA Approval for SYH2068 siRNA Clinical Trials

Grand Pharma Group and Sirtex Medical US Launch Commercial Partnership in Medical Innovation
CompanyDeals

Grand Pharma Group and Sirtex Medical US Launch Commercial Partnership in Medical Innovation

Shanghai Henlius and Alvogen Korea Ink Licensing Deal for HanSiZhuang (Serplulimab)
CompanyDeals

Shanghai Henlius and Alvogen Korea Ink Licensing Deal for HanSiZhuang (Serplulimab)

Digital-Intelligent Transformation of China's Pharmaceutical Industry: 2025-2030 Plan Unveiled
Policy / Regulatory

Digital-Intelligent Transformation of China’s Pharmaceutical Industry: 2025-2030 Plan Unveiled

Zhejiang Jolly Pharma Invests in Lingyi Biotech for Gene Therapy Development
CompanyDeals

Zhejiang Jolly Pharma Invests in Lingyi Biotech for Gene Therapy Development

Johnson & Johnson's Rybrevant Gains NMPA Approval for Expanded Lung Cancer Indication
CompanyDrug

Johnson & Johnson’s Rybrevant Gains NMPA Approval for Expanded Lung Cancer Indication

LTZ Therapeutics Secures $40M Series A+ to Advance Immunotherapy Pipeline
CompanyDeals

LTZ Therapeutics Secures $40M Series A+ to Advance Immunotherapy Pipeline

Amgen Announces $900M Investment to Expand Ohio Manufacturing
Company

Amgen Announces $900M Investment to Expand Ohio Manufacturing